BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1796265)

  • 1. [Experimental spinal cord injuries treated by calcium channel blockers].
    He FC; Liu YB
    Sheng Li Ke Xue Jin Zhan; 1991 Apr; 22(2):173-5. PubMed ID: 1796265
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of calcium channel blockers in experimental spinal cord injury.
    Anghelescu N; Petrescu A; Alexandrescu I
    Rom J Neurol Psychiatry; 1994; 32(2):101-9. PubMed ID: 8075019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Medical treatment of spinal cord injury during the acute phase. Effect of a calcium inhibitor].
    Pointillard V; Petitjean ME
    Agressologie; 1993; 34 Spec No 2():93-5. PubMed ID: 7802154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical applications of pharmacologic therapies for spinal cord injury.
    Zeidman SM; Ling GS; Ducker TB; Ellenbogen RG
    J Spinal Disord; 1996 Oct; 9(5):367-80. PubMed ID: 8938604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in phospholipids and acetylcholinesterase during early phase of injury to spinal cord--an experimental study in rats.
    Cherian L; Kuruvilla A; Chandy MJ; Abraham J
    Indian J Physiol Pharmacol; 1996 Apr; 40(2):134-8. PubMed ID: 9062807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuronal protection in neurologic diseases?].
    Bähr M; Eschweiler GW; Dichgans J
    Nervenarzt; 1994 Jun; 65(6):355-60. PubMed ID: 8072588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological management of spinal cord injury: current status of drugs designed to augment functional recovery of the injured human spinal cord.
    Greene KA; Marciano FF; Sonntag VK
    J Spinal Disord; 1996 Oct; 9(5):355-66. PubMed ID: 8938603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The therapeutic window for methylprednisolone treatment of acute spinal cord injury: implications for cell injury mechanisms.
    Young W
    Res Publ Assoc Res Nerv Ment Dis; 1993; 71():191-206. PubMed ID: 8417466
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure of nimodipine to reverse acute experimental spinal cord injury.
    Ford RW; Malm DN
    Cent Nerv Syst Trauma; 1985; 2(1):9-17. PubMed ID: 4092240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium influx and activation of calpain I mediate acute reactive gliosis in injured spinal cord.
    Du S; Rubin A; Klepper S; Barrett C; Kim YC; Rhim HW; Lee EB; Park CW; Markelonis GJ; Oh TH
    Exp Neurol; 1999 May; 157(1):96-105. PubMed ID: 10222112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of glutamate receptor blockers on glutamate release following spinal cord injury. Lack of evidence for an ongoing feedback cascade of damage --> glutamate release --> damage --> glutamate release --> etc.
    McAdoo DJ; Hughes MG; Nie L; Shah B; Clifton C; Fullwood S; Hulsebosch CE
    Brain Res; 2005 Mar; 1038(1):92-9. PubMed ID: 15748877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of fetal spinal cord graft with nerve growth factor and nimodipine in secondary injury of spinal cord of adult rat].
    Deng SL; Yuan T; Liao WH
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 Mar; 15(2):74-6. PubMed ID: 11286165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Cav2.3 calcium channel antagonist SNX-482 reduces dorsal horn neuronal responses in a rat model of chronic neuropathic pain.
    Matthews EA; Bee LA; Stephens GJ; Dickenson AH
    Eur J Neurosci; 2007 Jun; 25(12):3561-9. PubMed ID: 17610575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular actions and pharmacology of the calcium channel blocking drugs.
    Katz AM; Hager WD; Messineo FC; Pappano AJ
    Am J Med; 1984 Aug; 77(2B):2-10. PubMed ID: 6486125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel blockers ameliorate disease in a mouse model of multiple sclerosis.
    Brand-Schieber E; Werner P
    Exp Neurol; 2004 Sep; 189(1):5-9. PubMed ID: 15296830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative neuroprotective effect of sodium channel blockers after experimental spinal cord injury.
    Ates O; Cayli SR; Gurses I; Turkoz Y; Tarim O; Cakir CO; Kocak A
    J Clin Neurosci; 2007 Jul; 14(7):658-65. PubMed ID: 17532502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NS-7, a novel Na+/Ca2+ channel blocker, prevents neurologic injury after spinal cord ischemia in rabbits.
    Shi E; Kazui T; Jiang X; Washiyama N; Suzuki K; Yamashita K; Terada H
    J Thorac Cardiovasc Surg; 2005 Feb; 129(2):364-71. PubMed ID: 15678048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy in spinal cord injury: a critical review of recent developments.
    Faden AI
    Clin Neuropharmacol; 1987 Jun; 10(3):193-204. PubMed ID: 2842048
    [No Abstract]   [Full Text] [Related]  

  • 19. Spontaneous muscle action potentials are blocked by N-type and P/Q-calcium channels blockers in the rat spinal cord-muscle co-culture system.
    Taguchi K; Shiina M; Shibata K; Utsunomiya I; Miyatake T
    Brain Res; 2005 Feb; 1034(1-2):62-70. PubMed ID: 15713260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of calcium-regulating pharmacological preparations on the formation of a generator of pathologically enhanced excitation in the system of the dorsal horns of the spinal cord].
    Danilov EI; Grafova VN; Reshetniak VK
    Biull Eksp Biol Med; 1993 Sep; 116(9):288-90. PubMed ID: 8118004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.